388.35
-21.65(-5.28%)
Currency In INR
Sector
Healthcare
Industry
Biotechnology
Employees
16315
First IPO Date
April 07, 2004
| Name | Title | Pay | Year Born |
| Mr. Siddharth Mittal BCom, CA, CPA | MD, Chief Executive Officer & Director | 73.71M | 1978 |
| Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc. | Founder & Executive Chairperson | 42.28M | 1953 |
| Mr. Paul Vazhayil Thomas | Chief Commercial Officer, U.S. & Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business | 0 | 1973 |
| Mr. Saurabh Paliwal | Head of Investor Relations | 0 | N/A |
| Mr. Rajesh Shanoy | Company Secretary & Compliance Officer | 0 | N/A |
| Mr. Arun Gupta | Chief Operating Officer | 0 | N/A |
| Mr. Abhijit Zutshi | Chief Commercial Officer | 0 | N/A |
| Mr. Mukesh Kamath K | Interim Chief Financial Officer & Nodal Officer | 0 | N/A |
| Ms. Seema Shah Ahuja BA, MBA | SVice President & Global Head Corporate Communications & Corporate Brand Biocon Group | 0 | 1966 |
| Ms. Maninder Kapoor Puri | Head of Human Resources | 0 | 1973 |
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.